Xingke Rong Pharmaceuticals (06833.HK) released its interim results, with a net profit attributable to shareholders of 24.389 million yuan, an increase of 2.17% year-on-year.

Wisdom Financial News APP reported that Xingkerong Pharmaceutical (06833.HK) has released its financial results for the six months ending on June 30, 2025. The group achieved a revenue of 1.196 billion yuan, a decrease of 21.68% year-on-year. The net profit attributable to owners of the company was 24.389 million yuan, an increase of 2.17% year-on-year. Earnings per share were 0.012 yuan.